Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-09-01

Study Completion Date

2018-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to investigate the impact of preeclampsia on hemostasis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays

NCT05625763

Pre-Eclampsia

UNKNOWN

Thromboelastogram in Postdelivery Preeclamptic Patients

NCT03555630

Preeclampsia Coagulation Disorder Pregnancy Complications

COMPLETED

GROSS-HIST : Quantification of the Main Circulating Histones During Normal Pregnancy and Pregnancies With Placenta-mediated Complications

NCT04205383

Pregnancy Pregnancy Complications Healthy Volunteers

COMPLETED

Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire

NCT05191251

Peripartum Period Hemorrhage HEMSTOP Questionnaire

COMPLETED

Clinical Effectiveness of First Trimester Pre-eclampsia Screening Program.

NCT04021680

Pre-eclampsia

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In comparison to healthy pregnant women and non-pregnant woman, this study analyses parameters of primary hemostasis and plasmatic coaguation in preeclamptic pregnant woman. Detailed analyses of the platelet function is performed using the Multiple Electrode Aggregometry, detailed analyses of the plasmatic coagulation syste is performed by isolated coaguation factor analyses and conventional coagulation analyses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coagulation Disorder, Blood Platelet Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant Preeclampsia

Pregnant between 35th and 40th week of pregnancy Preeclampisa

Intervention: Aggregometry, Monitoring of plasmatic hemostasis: Aggregometry and conventional coagulation testing after blood sampling in the context of routinely performed blood sampling

Aggregometry, Monitoring of plasmatic hemostasis

Intervention Type DIAGNOSTIC_TEST

Multiple Electrode Aggregometry using the Multiplate system Coagulation factor analyses (FXIII, FVIII, vWF) Parameters of conventional coagulation testing (aPTT, INR, Platelet count)

Pregnant No-Preeclampsia

Control Group 1 Pregnant between 35th and 40th week of pregnancy No Preeclampsia Healthy Intervention: Aggregometry, Monitoring of plasmatic hemostasis: Aggregometry and conventional coagulation testing after blood sampling in the context of routinely performed blood sampling

Aggregometry, Monitoring of plasmatic hemostasis

Intervention Type DIAGNOSTIC_TEST

Multiple Electrode Aggregometry using the Multiplate system Coagulation factor analyses (FXIII, FVIII, vWF) Parameters of conventional coagulation testing (aPTT, INR, Platelet count)

Not Pregnant

Control group 2 Healthy and not pregnant control group

Intervention: Aggregometry, Monitoring of plasmatic hemostasis: Aggregometry and conventional coagulation testing after blood sampling.

Aggregometry, Monitoring of plasmatic hemostasis

Intervention Type DIAGNOSTIC_TEST

Multiple Electrode Aggregometry using the Multiplate system Coagulation factor analyses (FXIII, FVIII, vWF) Parameters of conventional coagulation testing (aPTT, INR, Platelet count)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aggregometry, Monitoring of plasmatic hemostasis

Multiple Electrode Aggregometry using the Multiplate system Coagulation factor analyses (FXIII, FVIII, vWF) Parameters of conventional coagulation testing (aPTT, INR, Platelet count)

Intervention Type DIAGNOSTIC_TEST